Who invested in BioClin?
BioClin's investors include Sofinnova Investments, Ysios Capital, HealthCap, Inkef and Life Sciences, and 2 more on record.
Who invested in BioClin
One round we have observed, with the 7 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$20Mraised across 1 round since 2018, from 1 source
- Latest round
- Series B, $20MMay 2018
- Investors
- 7
The rounds
- May 2018Series B$20M
Sofinnova Investments
Ysios Capital
HealthCap
Inkef- Life Sciences
- Sectoral Asset
- Tekla
Reported by FinSMEs
Everyone who backed them
Life Sciencesno record of our own yet1round
Sectoral Assetno record of our own yet1round
Teklano record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about BioClin
How much has BioClin raised?
BioClin has raised $20M across 1 round since 2018.
When did BioClin last raise?
BioClin's most recent round was a Series B of $20M in May 2018.
What was BioClin's biggest round?
Its most recent round, $20M in May 2018, is also its largest on record.
Who backed BioClin first?
BioClin's first round on record, in May 2018, was backed by Sofinnova Investments, Ysios Capital and HealthCap and 4 others.
What stage is BioClin at?
BioClin's latest named round is a Series B, in May 2018.
Companies like BioClin
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.